Scarletred

19/03/2026

🚀 will be exhibiting at in Denver! 🇺🇸

We are thrilled to announce that SCARLETRED Inc. will be exhibiting at the 2026 American Academy of Dermatology (AAD) Annual Meeting, taking place on March 27-31 in Denver, Colorado! 🌟

As one of the most influential global gatherings in dermatology, brings together clinicians, researchers, and industry leaders from around the world.

offers a high-profile platform to connect, learn, and advance the future of dermatology and skin care.

💡Let’s discuss how we can support precise skin endpoint documentation in your upcoming clinical trials and research.

📍Stop by our Booth #4515 & join us for conversations that matter.

🔗 Read more about our mission!

We are looking forward to meeting in Denver!

SCARLETRED will be exhibiting at the 2026 AAD Annual Meeting in Denver, Colorado. This incorporates a unique opportunity to connect with high-profile key opinion leaders, industry partners, and experts in dermatology.

16/03/2026

🚀 AI is transforming clinical skin imaging - but organisations are adopting it at different stages.

At Scarletred, we observe a clear progression in how AI enters dermatological research. We describe this evolution as the Three Waves of AI in Clinical Skin Imaging:

🌊 Wave 1 - Efficiency
Standardized imaging streamlines workflows across clinical trial sites and supports scalable, remote-friendly study designs.

🌊 Wave 2 - Quality
Clinical images become quantitative data, enabling precise measurement of parameters such as erythema, pigmentation, texture, lesion area, and 2D/3D metrics.

🌊 Wave 3 - Transformation
AI-driven scoring. The AI Agent ARORA® AI integrates multiple quantitative parameters to generate automated disease severity scores aligned with dermatological gold standards.

📱 Scarletred® Vision supports this evolution with a modular, smartphone-based platform for standardized imaging, quantitative analysis, and AI-assisted scoring.

🔬 The key question is:
Are you already riding the AI wave - and if so, which wave are you on?

🔗 Read the full article to find out which wave you are on.

At SCARLETRED, we observe that organizations adopt AI in distinct stages of maturity. We describe this evolution as the Three Waves of AI in Clinical Skin Imaging. Our framework helps to identify which AI wave you are on.

08/03/2026

🌟 Real growth starts with equal opportunities 🌟

This International Women's Day 2026, we proudly celebrate the women at SCARLETRED that are shaping the future of digital dermatology with their expertise in:

💡 Leadership
🔬 Clinical Research & Quality Assurance
🔧 Data Science & Engineering
🔎 Product & Business Development
🎨 Design & Marketing

Our female team plays a fundamental role in advancing clinical skin imaging and AI analysis, making digital dermatology accessible to clinicians and patients worldwide.

👏 We stand for equal opportunities every day - for all genders, cultures, ethnicities, and skin types.

Because every skin deserves precision, care, and innovation.

💫 Let’s advocate for equality - every day, together. 💫

07/03/2026

🤝 150 Years of Connection. A New Era of Clinical Imaging. 🤝

🗣️ On March 7, 1876, Patent No. 174.465 changed global communication forever.
☎️ 150 years ago, Alexander Graham Bell received the patent for the telephone.
🔎 Today, we are witnessing a similar shift - this time in clinical imaging.

The evolution of the is the base of our technology at SCARLETRED:

📲 Clinical Skin Imaging is becoming mobile.
🏥 High-precision analysis no longer requires bulky hardware.
🌍 Clinical Datasets can be created anywhere.

With Scarletred®Vision, every iOS and Android smartphone becomes a medical imaging device.

🔗 Find out how our Mobile Skin Imaging Solution works:
https://www.scarletred.com/products/vision?utm_source=facebook&utm_medium=organic_social&utm_campaign=telephone_anniversary

🤝 From transmitting voices to capturing clinical research data - innovation continues to redefine connection.

28/02/2026

🦋 We stand with patients, families, researchers, and clinicians worldwide — every day. 🦋

🫂 Today, on Rare Disease Day, we reaffirm our mission: advancing digital dermatology and improving care for rare diseases.

🗞️ We are honored to be featured in the nationwide journal (Seltene Krankheiten) for our 3D dermatology innovation in (EB).

affects roughly one in 50,000 births worldwide.
🔺 “Butterfly children” face extremely fragile skin, chronic wounds, and risks of serious complications.
🔺 Frequent hospital visits can be painful, stressful, and exhausting.

Scarletred®Vision is designed to change that — bringing safe, precise skin monitoring into patients’ homes:

🔎 A single smartphone image turns into a reliable clinical dataset – enabling mobile monitoring from home.
🔎 Scarletred®Vision detects, quantifies and monitors EB blisters over time.
🔎 This supports early intervention, treatment decisions, and improved wound care.

🛎 Stay tuned for more updates & read more in our article!

Scarletred®Vision enables 3D Assessment and Monitoring in Epidermolysis Bullosa (EB) with ARORA®AI. Beyond the detection of blisters, Scarletred®Vision assesses their stage and precisely measures their area, depth and volume.

25/02/2026

💉The rapid rise of ® and other GLP-1 receptor agonists is reshaping modern medicine. 💉

⚖️ What began as a therapy for type 2 diabetes is now widely used for weight management — with rapidly growing adoption across the US and Europe.

🔬 Alongside its clinical success, a new phenomenon has entered the discussion: ® Face.

🔺 ® Vision enables standardized digital skin imaging and quantitative analysis using smartphones — transforming visual changes into clinically actionable data.

🔎 Early detection supports informed clinical decisions, personalized aesthetic strategies, and structured longitudinal monitoring.

🔬As metabolic medicine evolves, so shall the tools we use to understand its dermatological impact.

🔗 Read about the Ozempic® Face and how Scarletred® Vision helps with detection and monitoring in our article.

Ozempic® is a GLP-1 therapy known for rapid weight loss, but it can also cause facial changes often referred to as Ozempic® Face. Scarletred® Vision allows early detection and monitoring of these changes.

17/09/2025

🇫🇷 We’re excited to announce our participation in from 17-20 September. Our team will be presenting two cutting-edge AI studies focused on transforming how skin conditions are objectively analysed and classified:

📌 Beyond Redness: AI-Driven Profiling of Rosacea Severity and Morphological Markers

📌 Objective Skin Typing Across the Spectrum: AI-Driven Fitzpatrick Classification from Facial Imagery

📩 Want to connect at the congress? Reach us at office@scarletred.



EADV - European Academy of Dermatology and Venereology Wirtschaftskammer Startups Go Global - Aussenwirtschaft Austria Austria Wirtschaftsservice Stadt Wien

30/05/2025

🤖 SCARLETRED unveils Arora AI at Expo2025 大阪・関西万博 Japan: Redefining the future of digital skin analysis! 🇯🇵✨

Now integrated into our new service Scarletred® Vision+, Arora AI delivers automated, AI-powered skin disease assessment that’s faster, smarter, for use in clinics, clinical trials, and remote care settings.

From psoriasis to alopecia and wound care, Arora AI adapts to all skin types and environments with unmatched precision.

📍 Experience Scarletred@Vision live at the Austrian Pavilion, EXPO 2025 Osaka
📩 Get in touch: office@scarletred.com

SCARLETRED unveils Aurora AI at EXPO 2025 Japan, an intelligent assistant integrated into our new service Scarletred®Vision+, automating skin disease analysis with unmatched speed, accuracy, and real-world usability.

26/05/2025

🔬 Just one day to go!

We’re excited to return as Expertise Partner at the 6th Annual Dermatology Drug Development Summit Europe 2025 in Berlin, starting tomorrow!

📍 Don’t miss our CEO Dr. Harald Schnidar speaking on the main stage at 11:30 AM, sharing insights on AI-powered innovation in dermatology drug development.

See you there!

22/05/2025

🔬SCARLETRED is heading to EADV Spring Symposium 2025 in Prague, 22–24 May!

Our team will be on-site from tomorrow, presenting two cutting-edge research posters powered by Scarletred® Vision, featuring AI-driven innovations in Alopecia Areata and Epidermolysis Bullosa.

📍 Join us in Prague and explore how digital innovation is transforming dermatology research.

SCARLETRED will attend the EADV Spring Symposium 2025 in Prague to present new research, showcasing our latest advancements in AI-driven dermatology and digital skin analysis about Alopecia areata and Epidermolysis bullosa.

13/05/2025

📚 Bridging academia and industry with AI-driven innovation!

SCARLETRED CEO Dr. Harald Schnidar is speaking today at MedUni Vienna, highlighting how digital health innovation and AI-powered platforms like Scarletred® Vision are shaping the future of academic R&D.

📍 Seminar: From Academia to Industry
🗓️ 13th of May, 14:00 | Seminar Room 06.L1.08 | Vienna General Hospital (AKH)

Proud to support the next generation of clinical research and digital health innovation!

SCARLETRED CEO Dr. Harald Schnidar speaks at MedUni Vienna on connecting academia and industry, showcasing how AI and SaaS solutions like Scarletred®Vision drive innovation in skin drug research and clinical development.

29/04/2025

🌸 We’re proud to sponsor the Cherry Blossom Business & Culture Event on May 9, 2025, at the Vienna Airport Conference & Innovation Center! 🇦🇹🇯🇵

Join us for a full day of Austria-Japan business networking, cultural exchange, panel discussions, concerts, and a live video connection to the Austrian Pavilion at EXPO 2025 Osaka, where Scarletred is proudly represented! 🎌✨

📍 Time: 9:30–17:00
🎟️ Register now: airportcity.at/cherry-blossom

Let's build bridges between innovation, culture, and global collaboration! 🌍